{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:39:38Z","timestamp":1794663578255,"version":"4.9.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["RG\/17\/12\/33167"],"award-info":[{"award-number":["RG\/17\/12\/33167"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Council","award":["MC_UU_00014\/4"],"award-info":[{"award-number":["MC_UU_00014\/4"]}]},{"name":"Medical Research Council","award":["MR\/T016701\/1"],"award-info":[{"award-number":["MR\/T016701\/1"]}]},{"DOI":"10.13039\/501100000317","name":"Action Medical Research","doi-asserted-by":"publisher","award":["GN2788"],"award-info":[{"award-number":["GN2788"]}],"id":[{"id":"10.13039\/501100000317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We systematically assessed the impact of metformin treatment on maternal pregnancy outcomes. PubMed, Ovid Embase, Medline, Web of Science, ClinicalTrials.gov and Cochrane databases were systematically searched (inception-1st February 2021). Randomised controlled trials reporting pregnancy outcomes in women randomised to metformin versus any other treatment for any indication were included. Outcomes included gestational weight gain (GWG), pre-eclampsia, gestational hypertension, preterm birth, gestational age at delivery, caesarean section, gestational diabetes, glycaemic control, and gastrointestinal side-effects. Two independent reviewers conducted screening, with a third available to evaluate disagreements. Risk-of-bias and GRADE assessments were conducted using Cochrane Risk-of-Bias and GRADE-pro software. Thirty-five studies (n\u2009=\u20098033 pregnancies) met eligibility criteria. GWG was lower in pregnancies randomised to metformin versus other treatments (1.57\u00a0kg\u2009\u00b1\u20090.60\u00a0kg; I\n                    <jats:sub>2<\/jats:sub>\n                    \u2009=\u200986%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001), as was likelihood of pre-eclampsia (OR 0.69, 95% CI 0.50\u20130.95; I\n                    <jats:sub>2<\/jats:sub>\n                    \u2009=\u200955%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.02). The risk of gastrointestinal side-effects was greater in metformin-exposed versus other treatment groups (OR 2.43, 95% CI 1.53\u20133.84; I\n                    <jats:sub>2<\/jats:sub>\n                    \u2009=\u200976%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0002). The risk of other maternal outcomes assessed was not significantly different between metformin-exposed versus other treatment groups. Metformin for any indication during pregnancy is associated with lower GWG and a modest reduced risk of pre-eclampsia, but increased gastrointestinal side-effects compared to other treatments.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-88650-5","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T06:05:37Z","timestamp":1619676337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Impact of metformin treatment during pregnancy on maternal outcomes: a systematic review\/meta-analysis"],"prefix":"10.1038","volume":"11","author":[{"given":"Jane L.","family":"Tarry-Adkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Ozanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine E.","family":"Aiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"88650_CR1","unstructured":"NICE Guidelines. Diabetes in pregnancy management from preconception to the postnatal period. www.nice.org.uk\/guidance\/ng3 (2015). Retrieved 25 Feb 2020."},{"key":"88650_CR2","unstructured":"Scottish Intercollegiate Guidelines Network. Management of diabetes a national clinical guideline. www.sign.ac.uk\/pdf\/sign116.pdf (2014). Cited 25 Feb 2020."},{"key":"88650_CR3","unstructured":"Diabetes in Pregnancy: Quick reference guide for health professionals on the screening, diagnosis and treatment of gestational diabetes in New Zealand. Wellington: Ministry of Health; 2014."},{"key":"88650_CR4","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.2337\/dc20-S014","volume":"43","author":"American Diabetes Association. 14","year":"2020","unstructured":"American Diabetes Association. 14. Management of diabetes in pregnancy: standards of medical care in diabetes\u20142020. Diabetes Care 43, S183\u2013S192 (2020).","journal-title":"Diabetes Care"},{"key":"88650_CR5","doi-asserted-by":"publisher","first-page":"e001258","DOI":"10.1136\/bmjgh-2018-001258","volume":"4","author":"C Moucheraud","year":"2019","unstructured":"Moucheraud, C., Lenz, C., Latkovic, M. & Wirtz, V. W. The costs of diabetes treatment in low-and middle income countries: a systematic review. BMJ Glob. Health 4, e001258 (2019).","journal-title":"BMJ Glob. Health"},{"key":"88650_CR6","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00125-017-4336-x","volume":"60","author":"E Sanchez-Rangel","year":"2017","unstructured":"Sanchez-Rangel, E. & Inzucchi, S. E. Metformin: clinical use in type 2 diabetes. Diabetologia 60, 1583\u20131593 (2017).","journal-title":"Diabetologia"},{"key":"88650_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/2042018810380215","volume":"1","author":"H Lashen","year":"2010","unstructured":"Lashen, H. Role of metformin in polycystic ovary syndrome. Ther. Adv. Endocrinol. Metab. 1, 117\u2013128 (2010).","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"88650_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-017-0670-9","volume":"7","author":"JM Dodd","year":"2018","unstructured":"Dodd, J. M., Grivell, R. M., Deussen, A. R. & Hague, W. M. Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes. Cochrane Syst. Rev. 7, 1\u201345 (2018).","journal-title":"Cochrane Syst. Rev."},{"key":"88650_CR9","first-page":"9804708","volume":"4","author":"L Guo","year":"2019","unstructured":"Guo, L. et al. Comparative efficacy and safety of metformin, glyburide, and insulin in treating gestational diabetes mellitus: a meta-analysis. J. Diabetes Res. 4, 9804708 (2019).","journal-title":"J. Diabetes Res."},{"key":"88650_CR10","first-page":"1","volume":"26","author":"LX Bao","year":"2019","unstructured":"Bao, L. X., Shi, W.-T. & Han, Y. X. Metformin versus insulin for gestational diabetes: a systematic review and meta-analysis. J. Matern. Fetal Neonatal Med. 26, 1\u201313 (2019).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"88650_CR11","doi-asserted-by":"publisher","first-page":"e1002848","DOI":"10.1371\/journal.pmed.1002848","volume":"16","author":"JL Tarry-Adkins","year":"2019","unstructured":"Tarry-Adkins, J. L., Aiken, C. E. & Ozanne, S. E. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLoS Med. 16, e1002848 (2019).","journal-title":"PLoS Med."},{"key":"88650_CR12","doi-asserted-by":"publisher","first-page":"e1003126","DOI":"10.1371\/journal.pmed.1003126","volume":"17","author":"JL Tarry-Adkins","year":"2020","unstructured":"Tarry-Adkins, J. L., Aiken, C. E. & Ozanne, S. E. Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: a systematic review and meta-analysis. PLoS Med. 17, e1003126 (2020).","journal-title":"PLoS Med."},{"key":"88650_CR13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2018.06.013","volume":"219","author":"LA Barbour","year":"2018","unstructured":"Barbour, L. A. et al. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am. J. Obstet. Gynecol. 219, e1\u2013e7 (2018).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"88650_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/2042098618769831","volume":"9","author":"TM Polasek","year":"2018","unstructured":"Polasek, T. M., Doogue, M. P. & Thynne, T. R. J. Metformin treatment of type 2 diabetes mellitus in pregnancy: update on safety and efficacy. Ther. Adv. Drug. Saf. 9, 287\u2013295 (2018).","journal-title":"Ther. Adv. Drug. Saf."},{"key":"88650_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/dme.13150","volume":"34","author":"S Butalia","year":"2017","unstructured":"Butalia, S. et al. Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis. Diabetes Med. 34, 27\u201336 (2017).","journal-title":"Diabetes Med."},{"key":"88650_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11845-016-1414-x","volume":"185","author":"B Zhu","year":"2016","unstructured":"Zhu, B. et al. Metformin versus insulin in gestational diabetes mellitus: a meta-analysis of randomized clinical trials. Ir. J. Med. Sci. 185, 371\u2013381 (2016).","journal-title":"Ir. J. Med. Sci."},{"key":"88650_CR17","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1080\/14767058.2016.1228061","volume":"30","author":"Y Feng","year":"2017","unstructured":"Feng, Y. & Yang, H. Metformin\u2014a potentially effective drug for gestational diabetes mellitus: a systematic review and meta-analysis. J. Matern. Fetal Neonatal Med. 30, 1874\u20131881 (2017).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"88650_CR18","doi-asserted-by":"publisher","first-page":"e3164","DOI":"10.1002\/dmrr.3164","volume":"35","author":"V D'Ambrosio","year":"2019","unstructured":"D\u2019Ambrosio, V. et al. (2019) Metformin reduces maternal weight gain in obese pregnant women: a systematic review and meta-analysis of two randomized controlled trials. Diabetes Metab. Res. Rev. 35, e3164 (2019).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"88650_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/dme.13523","volume":"35","author":"A Aqudah","year":"2018","unstructured":"Aqudah, A. et al. Risk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis. Diabetes Med. 35, 160\u2013172 (2018).","journal-title":"Diabetes Med."},{"key":"88650_CR20","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/uog.19084","volume":"52","author":"E Kalafat","year":"2018","unstructured":"Kalafat, E., Sukur, Y. E., Abdi, A., Thilaganathan, B. & Khalil, A. Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials. Ultrasound Obstet. Gynecol. 52, 706\u2013714 (2018).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"88650_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2019","unstructured":"Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 151, 264\u2013269 (2019).","journal-title":"Ann. Intern. Med."},{"key":"88650_CR22","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S2213-8587(15)00219-3","volume":"3","author":"C Chiswick","year":"2015","unstructured":"Chiswick, C. et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 3, 778\u2013786 (2015).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"88650_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S2213-8587(18)30310-3","volume":"7","author":"JM Dodd","year":"2019","unstructured":"Dodd, J. M. et al. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 7, 15\u201324 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"88650_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","volume":"7","author":"TS L\u00f8vvik","year":"2019","unstructured":"L\u00f8vvik, T. S. et al. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 7, 256\u2013266 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"88650_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.diabres.2014.10.001","volume":"107","author":"J Ainuddin","year":"2015","unstructured":"Ainuddin, J., Karim, N., Hasan, A. A. & Naqvi, S. A. Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country: a randomized control trial. Diabetes Res. Clin. Pract. 107, 290\u2013299 (2015).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"88650_CR26","doi-asserted-by":"publisher","first-page":"325851","DOI":"10.1155\/2015\/325851","volume":"2015","author":"J Ainuddin","year":"2015","unstructured":"Ainuddin, J., Karim, N., Zaheer, S., Ali, S. S. & Hasan, A. A. Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy. J. Diabetes Res. 2015, 325851 (2015).","journal-title":"J. Diabetes Res."},{"key":"88650_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.epag.2018.01.002","volume":"66","author":"SR Eid","year":"2018","unstructured":"Eid, S. R. et al. Is metformin a viable alternative to insulin in the treatment of gestational diabetes mellitus (GDM)? Comparison of maternal and neonatal outcomes. Egypt. Pediatr. Assoc. Gazette 66, 15\u201321 (2018).","journal-title":"Egypt. Pediatr. Assoc. Gazette"},{"key":"88650_CR28","first-page":"384","volume":"28","author":"JA Hassan","year":"2012","unstructured":"Hassan, J. A., Karem, N. & Sheikh, Z. Metformin prevents macrosomia and neonatal morbidity in gestational diabetes. Pak. J. Med. Sci. 28, 384\u2013389 (2012).","journal-title":"Pak. J. Med. Sci."},{"key":"88650_CR29","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/j.1471-0528.2010.02763.x","volume":"118","author":"H Ijas","year":"2011","unstructured":"Ijas, H. et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG 118, 880\u2013885 (2011).","journal-title":"BJOG"},{"key":"88650_CR30","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.diabres.2012.09.031","volume":"98","author":"S Niromanesh","year":"2012","unstructured":"Niromanesh, S. et al. Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial. Diabetes Res. Clin. Pract. 98, 422\u2013429 (2012).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"88650_CR31","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.14260\/jemds\/2016\/1011","volume":"5","author":"PS Somani","year":"2016","unstructured":"Somani, P. S., Sahana, P. K., Chaudhuri, P. & Sengupta, N. Treatment of gestational diabetes mellitus: insulin or metformin?. J. Evol. Med. Dent. Sci. 5, 4423\u20134429 (2016).","journal-title":"J. Evol. Med. Dent. Sci."},{"key":"88650_CR32","first-page":"332","volume":"40","author":"Z Nachum","year":"2017","unstructured":"Nachum, Z. et al. Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus: a randomized controlled study. Diabetes 40, 332\u2013337 (2017).","journal-title":"Diabetes"},{"key":"88650_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijgo.2010.04.028","volume":"11","author":"JC Silva","year":"2010","unstructured":"Silva, J. C. et al. Metformin compared with glyburide for the management of gestational diabetes. Int J. Gynaecol. Obstet. 11, 37\u201340 (2010).","journal-title":"Int J. Gynaecol. Obstet."},{"key":"88650_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1515\/jpm-2011-0175","volume":"40","author":"JC Silva","year":"2012","unstructured":"Silva, J. C., Fachin, D. R., Coral, M. L. & Bertini, A. M. Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus. J. Perinat. Med. 40, 225\u2013228 (2012).","journal-title":"J. Perinat. Med."},{"key":"88650_CR35","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","volume":"8","author":"DS Feig","year":"2020","unstructured":"Feig, D. S. et al. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 8, 834\u2013844 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"88650_CR36","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1509819","volume":"374","author":"A Syngelaki","year":"2016","unstructured":"Syngelaki, A. et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N. Engl. J. Med. 374, 434\u2013443 (2016).","journal-title":"N. Engl. J. Med."},{"key":"88650_CR37","first-page":"e-35338","volume":"30","author":"IB Nascimento","year":"2020","unstructured":"Nascimento, I. B., Sales, W. B. & Dienstmann, G. The impact of the use of metformine for obese pregnant women in prevention of pre-eclampsia. Sci. Med. Porto Alegre 30, e-35338 (2020).","journal-title":"Sci. Med. Porto Alegre"},{"key":"88650_CR38","first-page":"265","volume":"10","author":"A Jamal","year":"2012","unstructured":"Jamal, A., Milani, F. & Al-Yasin, A. Evaluation of the effect of metformin and aspirin on utero placental circulation of pregnant women with PCOS. Iran. J. Reprod. Med. 10, 265\u2013270 (2012).","journal-title":"Iran. J. Reprod. Med."},{"key":"88650_CR39","doi-asserted-by":"publisher","first-page":"E448","DOI":"10.1210\/jc.2010-0853","volume":"95","author":"E Vanky","year":"2010","unstructured":"Vanky, E. et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J. Clin. Endocrinol. Metab. 95, E448\u2013E455 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"88650_CR40","first-page":"17","volume":"4","author":"H Borg","year":"2016","unstructured":"Borg, H. & Ezat, S. Metformin opposed to insulin in the management of gestational Diabetes. Res. Obstet. Gynecol. 4, 17\u201326 (2016).","journal-title":"Res. Obstet. Gynecol."},{"key":"88650_CR41","first-page":"105","volume":"28","author":"RMA Khan","year":"2017","unstructured":"Khan, R. M. A., Mukhtar, A. & Khawar, A. Comparison of metformin with insulin in the management of gestational diabetes. Med. Forum Mon. 28, 105\u2013109 (2017).","journal-title":"Med. Forum Mon."},{"key":"88650_CR42","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","volume":"8","author":"JA Rowan","year":"2008","unstructured":"Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R. & Moore, P. Metformin versus insulin for the treatment of gestational diabetes. N. Engl. Med. 8, 2003\u20132015 (2008).","journal-title":"N. Engl. Med."},{"key":"88650_CR43","doi-asserted-by":"publisher","first-page":"3480629","DOI":"10.1155\/2016\/3480629","volume":"2016","author":"HS Saleh","year":"2016","unstructured":"Saleh, H. S., Abdelsalam, W. A., Mowafy, H. E. & Abd ElHameid, A. A. Could metformin manage gestational diabetes mellitus instead of insulin?. Int. J. Reprod. Med. 2016, 3480629 (2016).","journal-title":"Int. J. Reprod. Med."},{"key":"88650_CR44","doi-asserted-by":"publisher","first-page":"e1-7","DOI":"10.1016\/j.ajog.2013.03.022","volume":"209","author":"CP Spaulonci","year":"2013","unstructured":"Spaulonci, C. P., Bernardes, L. S., Trindade, T. C., Zugaib, M. & Francisco, R. P. Randomized trial of metformin vs insulin in the management of gestational diabetes. AJOG 209, e1-7 (2013).","journal-title":"AJOG"},{"key":"88650_CR45","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/dom.12017","volume":"15","author":"K Tertti","year":"2013","unstructured":"Tertti, K., Ekblad, U., Koskinen, P., Vahlberg, T. & Ronnemaa, T. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes. Metab. 15, 246\u2013251 (2013).","journal-title":"Diabetes Obes. Metab."},{"key":"88650_CR46","first-page":"823","volume":"13","author":"T Wasim","year":"2019","unstructured":"Wasim, T., Shaukat, S., Javaid, L., Mukhtar, S. & Amer, W. Comparison of metformin and insulin for management of gestational diabetes mellitus: a randomized control trial. Pak. J. Med. Sci. 13, 823\u2013827 (2019).","journal-title":"Pak. J. Med. Sci."},{"key":"88650_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/AOG.0b013e3181c52132","volume":"115","author":"LE Moore","year":"2010","unstructured":"Moore, L. E., Clokey, D., Rappaport, V. J. & Curet, L. B. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet. Gynecol. 115, 55\u201359 (2010).","journal-title":"Obstet. Gynecol."},{"key":"88650_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/ajo.12276","volume":"55","author":"A George","year":"2015","unstructured":"George, A. et al. Comparison of neonatal outcomes in women with gestational diabetes with moderate hyperglycaemia on metformin or glibenclamide\u2014a randomised controlled trial. Aust. N. Z. J. Obstet. Gynaecol. 55, 47\u201352 (2015).","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"88650_CR49","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.12669\/pjms.335.13286","volume":"33","author":"R Arshad","year":"2017","unstructured":"Arshad, R., Khanam, S., Shaikh, F. & Karim, N. Feto-maternal outcomes and glycemic control in metformin versus insulin treated gestational diabetics. Pak. J. Med. Sci. 33, 1182\u20131187 (2017).","journal-title":"Pak. J. Med. Sci."},{"key":"88650_CR50","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jog.12950","volume":"42","author":"S Ashoush","year":"2016","unstructured":"Ashoush, S., El-Said, M., Fathi, H. & Abdelnaby, M. Identification of metformin poor responders, requiring supplemental insulin, during randomization of metformin versus insulin for the control of gestational diabetes mellitus. J. Obstet. Gynaecol. Res. 42, 640\u2013647 (2016).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"88650_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3923\/rjog.2019.23.27","volume":"12","author":"M Galal","year":"2019","unstructured":"Galal, M., El Bassioune, W. M. & Sherif, L. Metformin versus insulin in treatment of gestational diabetes mellitus: A Randomized Controlled Trial. Res. J. Obst. Gynecol. 12, 23\u201327 (2019).","journal-title":"Res. J. Obst. Gynecol."},{"key":"88650_CR52","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1002\/jcp.27238","volume":"234","author":"N Ghomian","year":"2019","unstructured":"Ghomian, N. et al. The efficacy of metformin compared with insulin in regulating blood glucose levels during gestational diabetes mellitus: a randomized clinical trial. J. Cell Physiol. 234, 4695\u20134701 (2019).","journal-title":"J. Cell Physiol."},{"key":"88650_CR53","first-page":"327","volume":"4","author":"E Mesdaghinia","year":"2013","unstructured":"Mesdaghinia, E. et al. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: a randomised blinded trial. Int. J. Prev. Med. 4, 327\u2013333 (2013).","journal-title":"Int. J. Prev. Med."},{"key":"88650_CR54","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00404-013-3090-7","volume":"289","author":"MI Ibrahim","year":"2014","unstructured":"Ibrahim, M. I. et al. The role of adding metformin in insulin-resistant diabetic pregnant women: a randomized controlled trial. Arch. Gynecol. Obstet. 289, 959\u2013965 (2014).","journal-title":"Arch. Gynecol. Obstet."},{"key":"88650_CR55","first-page":"1011","volume":"52","author":"LE Moore","year":"2007","unstructured":"Moore, L. E. et al. Metformin and insulin in the management of gestational diabetes mellitus: preliminary results of a comparison. J. Reprod. Med. 52, 1011\u20131015 (2007).","journal-title":"J. Reprod. Med."},{"key":"88650_CR56","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jog.13477","volume":"44","author":"E Vald\u00e9s","year":"2018","unstructured":"Vald\u00e9s, E. et al. Metformin as a prophylactic treatment of gestational diabetes in pregnant patients with pregestational insulin resistance: a randomized study. J. Obstet. Gynaecol. Res. 44, 81\u201386 (2018).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"88650_CR57","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.diabet.2010.11.002","volume":"37","author":"M Bouchoucha","year":"2011","unstructured":"Bouchoucha, M., Uzzan, B. & Cohen, R. Metformin and digestive disorders. Diabetes Metab. 37, 90\u201396 (2011).","journal-title":"Diabetes Metab."},{"key":"88650_CR58","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2337\/db14-1388","volume":"64","author":"T Dujic","year":"2015","unstructured":"Dujic, T. et al. Association of organic cation transporter 1 with intolerance to metformin in type 2 diabetes: a GoDARTS study. Diabetes 64, 1786\u20131793 (2015).","journal-title":"Diabetes"},{"key":"88650_CR59","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/03670244.2012.696010","volume":"51","author":"M Bustos","year":"2012","unstructured":"Bustos, M., Venkataramanan, R. & Caritis, S. Appetite sensations and nausea and vomiting in pregnancy: an overview of the explanations. Ecol. Food Nutr. 51, 394\u2013417 (2012).","journal-title":"Ecol. Food Nutr."},{"key":"88650_CR60","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","volume":"578","author":"AP Coll","year":"2019","unstructured":"Coll, A. P. et al. GDF15 mediates the effects of metformin on body weight and energy balance. Nature 578, 444\u2013448 (2019).","journal-title":"Nature"},{"key":"88650_CR61","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/dme.13767","volume":"36","author":"CEM Aiken","year":"2019","unstructured":"Aiken, C. E. M., Hone, L., Murphy, H. R. & Meek, C. L. Improving outcomes in gestational diabetes: does gestational weight gain matter?. Diabet. Med. 36, 167\u2013176 (2019).","journal-title":"Diabet. Med."},{"key":"88650_CR62","first-page":"245","volume":"100","author":"BL Rooney","year":"2002","unstructured":"Rooney, B. L. & Schauberger, C. W. Excess pregnancy weight gain and long-term obesity: one decade later. Obstet. Gynecol. 100, 245\u2013252 (2002).","journal-title":"Obstet. Gynecol."},{"key":"88650_CR63","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/oby.2007.149","volume":"15","author":"AR Amorim","year":"2007","unstructured":"Amorim, A. R., R\u00f6ssner, S., Neovius, M., Louren\u00e7o, P. M. & Linn\u00e9, Y. Does excess pregnancy weight gain constitute a major risk for increasing long-term BMI?. Obesity (Silver Spring) 15, 1278\u20131286 (2007).","journal-title":"Obesity (Silver Spring)"},{"key":"88650_CR64","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/AOG.0b013e3181cfce4f","volume":"115","author":"MM Hedderson","year":"2010","unstructured":"Hedderson, M. M., Gunderson, E. P. & Ferrara, A. Gestational weight gain and risk of gestational diabetes mellitus. Obstet. Gynecol. 115, 597\u2013604 (2010).","journal-title":"Obstet. Gynecol."},{"key":"88650_CR65","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3945\/ajcn.110.008326","volume":"93","author":"A Fraser","year":"2011","unstructured":"Fraser, A. et al. Associations of gestational weight gain with maternal body mass index, waist circumference, and blood pressure measured 16 y after pregnancy: the avon longitudinal study of parents and children (ALSPAC). Am. J. Clin. Nutr. 93, 1285\u20131292 (2011).","journal-title":"Am. J. Clin. Nutr."},{"key":"88650_CR66","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12884-019-2566-2","volume":"19","author":"NEWD Teulings","year":"2019","unstructured":"Teulings, N. E. W. D., Masconi, K. L., Ozanne, S. E., Aiken, C. E. & Wood, A. M. Effect of interpregnancy weight change on perinatal outcomes: systematic review and meta-analysis. BMC Pregnancy Childbirth 19, 386 (2019).","journal-title":"BMC Pregnancy Childbirth"},{"key":"88650_CR67","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1001\/jama.2019.3820","volume":"321","author":"E Voerman","year":"2019","unstructured":"Voerman, E. et al. Association of gestational weight gain with adverse maternal and infant outcomes. JAMA 321, 1702\u20131715 (2019).","journal-title":"JAMA"},{"key":"88650_CR68","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.earlhumdev.2011.08.004","volume":"88","author":"S Schneider","year":"2012","unstructured":"Schneider, S., Freerksen, N., Rohrig, S., Hoeft, B. & Maul, H. Gestational diabetes and preeclampsia-similar risk factor profiles?. Early Hum. Dev. 88, 179\u2013184 (2012).","journal-title":"Early Hum. Dev."},{"key":"88650_CR69","first-page":"372","volume":"43","author":"MJ McMahon","year":"1998","unstructured":"McMahon, M. J., Ananth, C. V. & Liston, R. M. Gestational diabetes mellitus. Risk factors, obstetric complications and infant outcomes. J. Reprod. Med. 43, 372\u2013378 (1998).","journal-title":"J. Reprod. Med."},{"key":"88650_CR70","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ajog.2017.06.003","volume":"217","author":"R Romero","year":"2017","unstructured":"Romero, R. et al. Metformin, the aspirin of the 21st century: its role in gestational diabetes, prevention of preeclampsia and cancer, and the promotion of longevity. AJOG 217, 282\u2013302 (2017).","journal-title":"AJOG"},{"issue":"Suppl A","key":"88650_CR71","first-page":"S32","volume":"30","author":"JM Roberts","year":"2008","unstructured":"Roberts, J. M. & Hubel, C. A. The two stage model of pre-eclampsia: variations on the theme. Placenta 30(Suppl A), S32\u2013S37 (2008).","journal-title":"Placenta"},{"key":"88650_CR72","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1161\/01.HYP.0000188408.49896.c5","volume":"46","author":"JM Roberts","year":"2005","unstructured":"Roberts, J. M. & Gammill, H. S. Preeclampsia: recent insights. Hypertension 46, 1243\u20131249 (2005).","journal-title":"Hypertension"},{"key":"88650_CR73","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1055\/s-0038-1675214","volume":"40","author":"IBD Nascimento","year":"2018","unstructured":"Nascimento, I. B. D. et al. Evaluation of preeclampsia results after use of metformin in gestation: systematic review and meta-analysis. Rev. Bras. Ginecol. Obstet. 40, 713\u2013721 (2018).","journal-title":"Rev. Bras. Ginecol. Obstet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88650-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T19:21:28Z","timestamp":1675192888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88650-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88650"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88650-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-112670\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,29]]},"assertion":[{"value":"20 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9240"}}